InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,478.06
(
0.00%
)
US TECH 100
19,266.80
(
0.27%
)
Dow Jones
39,141.20
(
0.03%
)
Brent Oil
85.36
(
1.05%
)
Bitcoin
61,427.79
(
1.01%
)
Post# of 252404
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

efar

Send PM Follow Ignore
Followers 0
Posts 60
Boards Moderated 0
Alias Born 01/06/2010

efar

Re: tony111 post# 116663

Wednesday, 03/23/2011 1:45:28 PM

Wednesday, March 23, 2011 1:45:28 PM

Post# of 252404

CYTK

Its a good short... They are running short of cash and the myosin activator data won't be out for another year. They will be forced to do an offer below 1 for sure. I will not touch it unless they do an offering.




FWIW Andrew Vaino at Roth (one of the better small cap pharma analysts out there) started CYTK at a buy today with a 3.5 target, his 28 page report is worth a read.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up